Literature DB >> 23734033

Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes.

Doreen M Rabi1, Raj Padwal, Sheldon W Tobe, Richard E Gilbert, Lawrence A Leiter, Robert R Quinn, Nadia Khan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23734033      PMCID： PMC3735744          DOI： 10.1503/cmaj.120112

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  15 in total

1.  Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Iryna Lobach; Franz H Messerli
Journal:  Circulation       Date:  2011-05-31       Impact factor: 29.690

2.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.

Authors:  A I Adler; I M Stratton; H A Neil; J S Yudkin; D R Matthews; C A Cull; A D Wright; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

Review 3.  The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Authors:  Stella S Daskalopoulou; Nadia A Khan; Robert R Quinn; Marcel Ruzicka; Donald W McKay; Daniel G Hackam; Simon W Rabkin; Doreen M Rabi; Richard E Gilbert; Raj S Padwal; Martin Dawes; Rhian M Touyz; Tavis S Campbell; Lyne Cloutier; Steven Grover; George Honos; Robert J Herman; Ernesto L Schiffrin; Peter Bolli; Thomas Wilson; Ross D Feldman; M Patrice Lindsay; Brenda R Hemmelgarn; Michael D Hill; Mark Gelfer; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Simon L Bacon; Robert J Petrella; Alain Milot; James A Stone; Denis Drouin; Maxime Lamarre-Cliché; Marshall Godwin; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; Brian Penner; Robert A Hegele; Philip A McFarlane; Mukul Sharma; Norman R C Campbell; Debra Reid; Luc Poirier; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2012-05       Impact factor: 5.223

4.  Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.

Authors:  Robert W Schrier; Raymond O Estacio; Anne Esler; Philip Mehler
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

5.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

6.  Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients.

Authors:  Gianpaolo Reboldi; Giorgio Gentile; Fabio Angeli; Giuseppe Ambrosio; Giuseppe Mancia; Paolo Verdecchia
Journal:  J Hypertens       Date:  2011-07       Impact factor: 4.844

Review 7.  Analysis and reporting of factorial trials: a systematic review.

Authors:  Finlay A McAlister; Sharon E Straus; David L Sackett; Douglas G Altman
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

8.  The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Authors:  Nadia A Khan; Finlay A McAlister; Norman R C Campbell; Ross D Feldman; Simon Rabkin; Jeff Mahon; Richard Lewanczuk; Kelly B Zarnke; Brenda Hemmelgarn; Marcel Lebel; Mitchell Levine; Carol Herbert
Journal:  Can J Cardiol       Date:  2004-01       Impact factor: 5.223

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Authors:  Fiona Turnbull
Journal:  Lancet       Date:  2003-11-08       Impact factor: 79.321
View more
  7 in total

1.  Arterial wall function is associated with cognitive performance primarily in elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Salo Haratz; David Tanne; James Schmeidler; Shai Efrati; Clive Rosendorff; Michal Schnaider Beeri; Jeremy M Silverman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Cardiovascular inflammation is reduced with methotrexate in diabetes.

Authors:  Adrian Quan; Yi Pan; Krishna K Singh; John Polemidiotis; Hwee Teoh; Howard Leong-Poi; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2017-03-16       Impact factor: 3.396

3.  Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis.

Authors:  Debra L Foley; Andrew Mackinnon; Vera A Morgan; Gerald F Watts; John J McGrath; David J Castle; Anna Waterreus; Cherrie A Galletly
Journal:  World Psychiatry       Date:  2014-06       Impact factor: 49.548

4.  Clinical Significance of Arterial Stiffness and Thickness Biomarkers in Type 2 Diabetes Mellitus: An Up-To-Date Meta-Analysis.

Authors:  Yang Yapei; Ren Xiaoyan; Zeng Sha; Pan Li; Meng Xiao; Chen Shuangfeng; Wang Lexin; Cui Lianqun
Journal:  Med Sci Monit       Date:  2015-08-21

5.  Quality of Blood Pressure Tracking Apps for the iPhone: Content Analysis and Evaluation of Adherence With Home Blood Pressure Measurement Best Practices.

Authors:  Amanda Y Leong; Mark J Makowsky
Journal:  JMIR Mhealth Uhealth       Date:  2019-04-12       Impact factor: 4.773

6.  A Canadian perspective on the Eighth Joint National Committee (JNC 8) hypertension guidelines.

Authors:  Martin G Myers; Sheldon W Tobe
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-19       Impact factor: 3.738

7.  Hypertension management for community-dwelling older people with diabetes in Nanchang, China: study protocol for a cluster randomized controlled trial.

Authors:  Qiang Tu; Lily Dongxia Xiao; Shahid Ullah; Jeffrey Fuller; Huiyun Du
Journal:  Trials       Date:  2018-07-16       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.